<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05073445</url>
  </required_header>
  <id_info>
    <org_study_id>IRB 02021 - 097</org_study_id>
    <nct_id>NCT05073445</nct_id>
  </id_info>
  <brief_title>Stress and Resilience in Anesthesia Professionals</brief_title>
  <acronym>ResiStress</acronym>
  <official_title>Stress and Resilience in Anesthesia Professionals</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Grenoble</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Grenoble</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study was to analyze the correlation between the resilience of anesthesia&#xD;
      professionals and the stress measured during a simulation session.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This trial will be carried out at the simulation center of the training institute for health&#xD;
      professionals of the CHU Grenoble Alpes. Volunteer anesthesia professionals and students will&#xD;
      perform a scenario simulating a pediatric laryngospasm during a surgical incision.&#xD;
&#xD;
      Each scenario will be performed by a medical and paramedical anesthesia pair and supervised&#xD;
      by simulation trainers.&#xD;
&#xD;
      Stress and resilience measures will be taken at various times during the study. Participants&#xD;
      will be debriefed at the end of the simulation.&#xD;
&#xD;
      The primary objective is to analyze the correlation between anesthesia professionals'&#xD;
      resilience and measured stress.Secondary objectives are to study the association between:&#xD;
      SDNN-measured stress and VAS-reported stress, age and SDNN-measured stress, CD RISC 10&#xD;
      resilience and PSS10-reported stress, CD RISC resilience and VAS-reported stress, the effect&#xD;
      of experience on SDNN-measured stress, multiple correlation of the different secondary&#xD;
      criteria.&#xD;
&#xD;
      secondary criteria.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 18, 2021</start_date>
  <completion_date type="Anticipated">September 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">September 29, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Heart rate variability</measure>
    <time_frame>during the laryngospasm (during 3 minutes at 6 minutes)</time_frame>
    <description>Standard deviation of the average of RR intervals (SDNN in milliseconds) in participants</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Resilience</measure>
    <time_frame>5 days before scenario</time_frame>
    <description>Measurement of resilience by Connor-Davidson Resilience Scale 10 (CD RISC 10 from 0 to 40) in participants. A high score indicates better resilience.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Self-reported stress</measure>
    <time_frame>5 days before scenario</time_frame>
    <description>Stress level self reported by participants on visual analogical scale (VAS from 0 to 100); One end of the scale represents the maximum conceivable symptom strength (i. e., 100%), the other end no symptoms whatsoever (i. e., 0%).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-reported stress</measure>
    <time_frame>just Before the scenario (at 0 minute )</time_frame>
    <description>Stress level self reported by participants on visual analogical scale (VAS from 0 to 100); One end of the scale represents the maximum conceivable symptom strength (i. e., 100%), the other end no symptoms whatsoever (i. e., 0%).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-reported stress</measure>
    <time_frame>just after briefing (at 3 minutes)</time_frame>
    <description>Stress level self reported by participants on visual analogical scale (VAS from 0 to 100); One end of the scale represents the maximum conceivable symptom strength (i. e., 100%), the other end no symptoms whatsoever (i. e., 0%).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-reported stress</measure>
    <time_frame>just after the end of scenario (at 9 minutes)</time_frame>
    <description>Stress level self reported by participants on visual analogical scale (VAS from 0 to 100); One end of the scale represents the maximum conceivable symptom strength (i. e., 100%), the other end no symptoms whatsoever (i. e., 0%).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-reported stress</measure>
    <time_frame>just after the debriefing (at 30 minutes)</time_frame>
    <description>Stress level self reported by participants on visual analogical scale (VAS from 0 to 100); One end of the scale represents the maximum conceivable symptom strength (i. e., 100%), the other end no symptoms whatsoever (i. e., 0%).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Perceived Stress Scale</measure>
    <time_frame>5 days before scenario</time_frame>
    <description>The Perceived Stress Scale (PSS10 from 10 To 50) measures the degree to which respondents feel their lives are unpredictable, uncontrollable, and overloaded. A high score indicates more stress.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Age of anesthesia professionals</measure>
    <time_frame>5 days before scenario</time_frame>
    <description>Age of anesthesia professionals: (quantitative variable)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Experience in anesthesia:</measure>
    <time_frame>5 days before scenario</time_frame>
    <description>Experience in anesthesia: number of years since the beginning of specialized training training (quantitative variable)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pediatric experience:</measure>
    <time_frame>5 days before scenario</time_frame>
    <description>Pediatric experience: qualitative variable (yes, no)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pediatric laryngospasm experience</measure>
    <time_frame>5 days before scenario</time_frame>
    <description>Pediatric laryngospasm experience: qualitative variable: (yes, no)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart rate variability</measure>
    <time_frame>5 days before scenario (during 3 minutes)</time_frame>
    <description>Standard deviation of the average of RR intervals (SDNN in milliseconds) in participants</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart rate variability</measure>
    <time_frame>Before the scenario (during 3 minutes)</time_frame>
    <description>Standard deviation of the average of RR intervals (SDNN in milliseconds) in participants</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart rate variability</measure>
    <time_frame>during briefing (during 3 minutes at 0 minutes)</time_frame>
    <description>Standard deviation of the average of RR intervals (SDNN in milliseconds) in participants</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart rate variability</measure>
    <time_frame>during the scenario before the laryngospasm (during 3 minutes at 3 minutes)</time_frame>
    <description>Standard deviation of the average of RR intervals (SDNN in milliseconds) in participants</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart rate variability</measure>
    <time_frame>during the debriefing (3 minutes at 9 minutes)</time_frame>
    <description>Standard deviation of the average of RR intervals (SDNN in milliseconds) in participants</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart rate variability</measure>
    <time_frame>after the debriefing (3 minutes at 30 minutes)</time_frame>
    <description>Standard deviation of the average of RR intervals (SDNN in milliseconds) in participants</description>
  </secondary_outcome>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Stress, Professional</condition>
  <condition>Resilience</condition>
  <condition>Anaesthesiology</condition>
  <condition>High Fidelity Simulation</condition>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>SDNN measurement</intervention_name>
    <description>SDNN measurement during pediatric simulation</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Anaesthetic teams composed with :&#xD;
&#xD;
          -  1 resident in anaesthesiology and critical care OR Anesthesiologist AND&#xD;
&#xD;
          -  1 anaesthetic nursing student OR 1 anaesthetic nurse graduated&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        - volunteer in anesthesia&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Rhythm disorders&#xD;
&#xD;
          -  Endocrine pathology&#xD;
&#xD;
          -  High blood pressure&#xD;
&#xD;
          -  Pregnancy or breastfeeding in progress&#xD;
&#xD;
          -  Taking anti-inflammatory or psychotropic drugs that interfere with the heart rate&#xD;
&#xD;
          -  Interruption of professional practice in anesthesia &gt; 2 years&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yoann Zafiriou</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Grenoble</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Julien Picard, M.D, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Grenoble</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Pierre Albaladejo, M.D, Ph.D.</last_name>
    <phone>+33 (0)4 76 76 92 88</phone>
    <email>PAlbaladejo@chu-grenoble.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Julien Picard, M.D, Ph.D.</last_name>
    <phone>+33 (0)4 76 76 92 88</phone>
    <email>JPicard@chu-grenoble.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Hospital</name>
      <address>
        <city>Grenoble</city>
        <zip>38000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julien PICARD, Dr</last_name>
      <email>jpicard@chu-grenoble.fr</email>
    </contact>
    <contact_backup>
      <last_name>Yoann ZAFIRIOU</last_name>
      <email>yzafiriou@chu-grenoble.fr</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>July 29, 2021</study_first_submitted>
  <study_first_submitted_qc>September 28, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 11, 2021</study_first_posted>
  <last_update_submitted>September 28, 2021</last_update_submitted>
  <last_update_submitted_qc>September 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Occupational Stress</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

